α-Synuclein: Normal Function and Role in Neurodegenerative Diseases

Current Topics in Developmental Biology

Volumn 60, Issue , 2004, Pages 17-54

  Norris, Erin H ^a   Giasson, Benoit I ^a   Lee, Virginia M Y ^a  

^a Laboratory Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; NERVE PROTEIN; NITROGEN; OXYGEN; PESTICIDE; SNCA PROTEIN, HUMAN; SYNUCLEIN;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMICAL MODEL; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; LEWY BODY; METABOLISM; MOLECULAR GENETICS; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; REVIEW; SEQUENCE HOMOLOGY; SHY DRAGER SYNDROME; TRANSGENIC ANIMAL;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DEMENTIA; HUMANS; LEWY BODIES; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NITROGEN; OXYGEN; PARKINSON DISEASE; PESTICIDES; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SYNUCLEINS;

EID: 2642514788     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(04)60002-0     Document Type: Article

References (256)

1. D Aarland E Tangberg J.P Larsen J.L Cummings Frequency of dementia in Parkinson's disease Arch. Neurol. 53 1996 538 542
2. A Abeliovich Y Schmitz I Farinas D Choi-Lundberg W.H Ho P.E Catillo N Shinsky J.M Verdugo M Armanini A Ryan M Hynes H Phillips D Sulzer A Rosenthal Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system Neuron 25 2000 239 252
3. R.D Adams L van Bogaert H van der Eecken Striato-nigral degeneration J. Neuropathol. Exp. Neurol. 23 1964 584 608
4. C Alves da Costa K Ancolio F Checler Wild-type but not Parkinson's disease-related Ala53-Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli J. Biol. Chem. 275 2000 24065 24069
5. K Arai N Kato K Kashiwado T Hattori Pure autonomic failure in association with human alpha-synucleinopathy Neurosci. Lett. 296 2000 171 173
6. S Arawaka Y Saito S Murayama H Mori Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein Neurology 51 1998 887 889
7. K Arima S Murayama M Mukoyama T Inose Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy Acta Neuropathol. (Berl.) 83 1992 453 460
8. K Arima K Ueda N Sunohara K Arakawa S Hirai M Nakamura H Tonozuka-Uehara M Kawai NACP⧸alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy Acta Neuropathol. (Berl.) 96 1998 439 444
9. V Askanas W.K Engel R.B Alvarez J McFerrin A Broccolini Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions J. Neuropathol. Exp. Neurol. 59 2000 592 598
10. M Baba S Nakajo P.H Tu T Tomita K Nakaya V.M.-Y Lee J.Q Trojanowski T Iwatsubo Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am. J. Pathol. 152 1998 879 884
11. P.A Barbeau T Cloutier L Plasse S Paris Environmental and genetic factors in the etiology of Parkinson's disease Adv. Neurol. 45 1986 299 306
12. P.A Barbeau M Roy G Bernier G Campanella S Paris Ecogenetics of Parkinson's disease Can. J. Neurol. Sci. 14 1987 36 41
13. T.A Bayer P Jakala T Hartmann L Havas C McLean J.G Culvenor Q.X Li C.L Masters P Falkai K Beyreuther alpha-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid cores Neurosci. Lett. 266 1999 213 216
14. J.S Beckman W.H Koppenol Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly Am. J. Physiol. 271 1996 C1424 C1437
15. R Betarbet T.B Sherer G MacKenzie M Garcia-Osuna A.V Panov J.T Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
16. A.L Biere S.J Wood J Wypych S Steavenson Y Jiang D Anafi F.W Jacobsen M.A Jarosinski G.M Wu J.C Louis F Martin L.O Narhi M Citron Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs J. Biol. Chem. 275 2000 34574 34579
17. B.F Boeve M.H Silber T.J Ferman E Kokmen G.E Smith R.J Ivnik J.E Parisi E.J Olson R.C Petersen REM sleep behavior disorder and degenerative dementia: An association likely regliecting Lewy body disease Neurology 51 1998 363 370
18. A.P Breen J.A Murphy Reactions of oxyl radicals with DNA Free Radic. Biol. Med. 18 1995 1033 1077
19. R.G Brown C.D Marsden How common is dementia in Parkinson's disease? Lancet 2 1984 1262 1265
20. W Bruening B.I Giasson A.J Klein-Szanto V.M.-Y Lee J.Q Trojanowski A.K Godwin Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary Cancer 88 2000 2154 2163
21. V.L Buchman J Adu L.G Pinon N.N Ninkina A.M Davies Persyn, a member of the synuclein family, influences neurofilament network integrity Nature Neurosci. 1 1998 101 103
22. V.L Buchman H.J Hunter L.G Pinon J.A Thompson E.M Privalova N.N Ninkina A.M Davies Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system J. Neurosci. 8 1998 9335 9341
23. L Buee T Bussiere V Buee-Scherrer A Delacourte P.R Hof Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res. Rev. 33 2000 95
24. D.E Cabin K Shimazu D.D Murphy N.B Cole W Gottschalk K.L McIIwain B Orrison A Chen C.E Ellis R Paylor B Lu R.L Nussbaum Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein J. Neurosci. 22 2002 8797 8807
25. Y.G Chen A Siddhanta C.D Austin S.M Hammond T.C Sung M.A Frohman A.J Morris D Shields Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network J. Cell Biol. 138 1997 495 504
26. D.F Clayton J.M George Synucleins in synaptic plasticity and neurodegenerative disorders J. Neurosci. Res. 58 1999 120 129
27. L Clejan A.I Cederbaum Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals Biochem. Pharmacol. 38 1989 1779 1786
28. K.A Conway J.D Harper P.T Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
29. K.A Conway J.D Harper P.T Lansbury Jr. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid Biochemistry 39 2000 2552 2563
30. K.A Conway S.J Lee J.C Rochet T.T Ding J.D Harper R.E Williamson P.T Lansbury Jr. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants Ann. N. Y. Acad. Sci. 920 2000 42 45
31. K.A Conway S.J Lee J.C Rochet T.T Ding R.E Williamson P.T Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy Proc. Natl. Acad. Sci. USA 97 2000 571 576
32. K.A Conway J.C Rochet R.M Bieganski P.T Lansbury Jr. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct Science 294 2001 1346 1349
33. R.A Crowther S.E Daniel M Goedert Characterization of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain Neurosci. Lett. 292 2000 128 130
34. R.A Crowther R Jakes M.G Spillantini M Goedert Synthetic filaments assembled from C-terminally truncated alpha-synuclein FEBS Lett. 436 1998 309 312
35. A.S Crystal B.I Giasson A Crowe M.P Kung Z.P Zhuang J.Q Trojanowski V.M.-Y Lee A comparison of amyloid fibrillogenesis using the novel fluorescent compound, K114 J. Neurochem. 86 2003 1359 1368
36. H.A Crystal D.W Dickson J.E Lizardi P Davies L.I Wolfson Antemortem diagnosis of diffuse Lewy body disease Neurology 40 1990 1523 1528
37. P Damier E.C Hirsch Y Agid A.M Graybiel The substantia nigra of the human brain. II. Pattern of loss of dopamine-containing neurons in Parkinson's disease Brain 122 1999 1437 1448
38. W Dauer N Kholodilov M Vila A.-C Trillat R Goodchild K.E Larsen R Staal K Tieu Y Schmitz C.A Yuan M Rocha V Jackson-Lewis S Hersch D Sulzer S Przedborski R Burke R Hen Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP Proc. Natl. Acad. Sci. USA 99 2002 14524 14529
39. W.S Davidson A Jonas D.F Clayton J.M George Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes J. Biol. Chem. 273 1998 9443 9449
40. K.J Davies M.E Delsignore S.W Lin Protein damage and degradation by oxygen radicals. II. Modification of amino acids J. Biol. Chem. 262 1987 9902 9907
41. J Dejerine A.A Thomas L'atrophie olivo-ponto-cerebelleuse Nouv Iconog. Salpetriere 13 1900 330 370
42. D.W Dickson W Liu J Hardy M Farrer N Mehta R Uitti M Mark T Zimmerman L Golbe J Sage A Sima C D'Amato R Albin S Gilman S.H Yen Widespread alterations of alpha-synuclein in multiple system atrophy Am. J. Pathol. 155 1999 1241 1251
43. E.C Dooling W.C Schoene E.P Richardson Hallervorden-Spatz syndrome Arch. Neurol. 30 1974 70 83
44. J.E Duda B.I Giasson Q Chen T.L Gur H.I Hurtig M.B Stern S.M Gollomp H Ischiropoulos V.M.-Y Lee J.Q Trojanowski Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Am. J. Pathol. 157 2000 1439 1445
45. J.E Duda B.I Giasson T.L Gur T.J Montine D Robertson I Biaggioni H.I Hurtig M.B Stern S.M Gollomp M Grossman V.M.-Y Lee J.Q Trojanowski Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy J. Neuropathol. Exp. Neurol. 59 2000 830 841
46. J.E Duda B.I Giasson M.E Mabon V.M.-Y Lee J.Q Trojanowski Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases Ann. Neurol. 52 2002 205 210
47. J.E Duda B.I Giasson M.E Mabon D.C Miller L.I Golbe V.M.-Y Lee J.Q Trojanowski Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred Acta Neuropathol. (Berl.) 104 2002 7 11
48. J.E Duda V.M.-Y Lee J.Q Trojanowski Neuropathology of synuclein aggregates J. Neurosci. Res. 61 2000 121 127
49. Duda ,J. E., Shah, U., Arnold, S. E., Lee, V. M.-Y., and Trojanowski, J. Q. (1999). The expression of a-, b-, and g-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp. Neurol. 160, 551–522.
50. P.E Duffy V.M Tennyson Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus ceruleus in Parkinson's disease J. Neuropathol. Exp. Neurol. 24 1965 398 414
51. O.M El Agnaf A.M Bodles D.J Guthrie P Harriott G.B Irvine The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils Eur. J. Biochem. 258 1998 157 163
52. O.M El Agnaf R Jakes M.D Curran A Wallace Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease FEBS Lett. 440 1998 67 70
53. D Eliezer E Kutluay R Bussell Jr. G Browne Conformational properties of alpha-synuclein in its free and lipid-associated states J. Mol. Biol. 307 2001 1061 1073
54. C.E Ellis P.L Schwartzberg T.L Grider D.W Fink R.L Nussbaum Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases J. Biol. Chem. 276 2001 3879 3884
55. S Engelender Z Kaminsky X Guo A.H Sharp R.K Amaravi J.J Kleiderlein R.L Margolis J.C Troncoso A.A Lanahan P.F Worley V.L Dawson T.M Dawson C.A Ross Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions Nat. Genet. 22 1999 110 114
56. J.H Exton Phospholipase D: Enzymology, mechanisms of regulation, and function Physiol. Rev. 77 1997 303 320
57. M.S Forman M.L Schmidt S Kasturi D.P Perl V.M.-Y Lee J.Q Trojanowski Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam Am. J. Pathol. 160 2002 1725 1731
58. L.S Forno Neuropathology of Parkinson's disease J. Neuropathol. Exp. Neurol. 55 1996 259 272
59. A Fredriksson M Fredriksson P Eriksson Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice Toxicol. Appl. Pharmacol. 122 1993 258 264
60. K.M Fung L.B Rorke B Giasson V.M.-Y Lee J.Q Trojanowski Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas Acta Neuropathol. 106 2003 167 175
61. W.P Gai D.L Pountney J.H Power Q.X Li J.G Culvenor C.A McLean P.H Jensen P.C Blumbergs Alpha-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy Exp. Neurol. 18 2003 68 78
62. W.P Gai J.H Power P.C Blumbergs W.W Blessing Multiple system atrophy: A new synuclein disease? Lancet 352 1998 547 548
63. W.P Gai J.H Power P.C Blumbergs J.G Culvenor P.H Jensen Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components J. Neurochem. 73 1999 2093 2100
64. W.P Gai H.X Yuan X.Q Li J.H Power P.C Blumbergs P.H Jensen In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies Exp. Neurol. 166 2000 324 333
65. D Galasko L.A Hansen R Katzman W Wiederholt E Masliah R Terry L.R Hill P Lessin L.J Thal Clinical-neuropathological correlations in Alzheimer's disease and related dementias Arch. Neurol. 51 1994 888 895
66. J.E Galvin B Giasson H.I Hurtig V.M.-Y Lee J.Q Trojanowski Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology Am. J. Pathol. 157 2000 361 368
67. J.E Galvin T.M Schuck V.M.-Y Lee J.Q Trojanowski Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra Exp. Neurol. 168 2001 347 355
68. J.M George The synucleins Genome Biol. 3 2001 1 6
69. J.M George H Jin W.S Woods D.F Clayton Characterization of a novel protein regulated during the critical period for song learning in the zebra finch Neuron 15 1995 361 372
70. B.I Giassion V.M.-Y Lee Are ubiquitination pathways central to Parkinson's disease? Cell 114 2003 1 8
71. B.I Giasson J.E Duda I.V Murray Q Chen J.M Souza H.I Hurtig H Ischiropoulos J.Q Trojanowski V.M.-Y Lee Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
72. B.I Giasson R Jakes M Goedert J.E Duda S Leight J.Q Trojanowski V.M.-Y Lee A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease J. Neurosci. Res. 59 2000 528 533
73. B.I Giasson J.E Duda S.M Quinn B Zhang J.Q Trojanowski V.M.-Y Lee Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
74. B.I Giasson M.S Forman M Higuchi L.I Golbe C.L Graves P.T Kotzbauer J.Q Trojanowski V.M.-Y Lee Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636 640
75. B.I Giasson I.V Murray J.Q Trojanowski V.M.-Y Lee A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly J. Biol. Chem. 276 2001 2380 2386
76. B.I Giasson K Uryu J.Q Trojanowski V.M.-Y Lee Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro J. Biol. Chem. 274 1999 7619 7622
77. W.R.G Gibb M.M Esiri A.J Lees Clinical and pathological features of diffuse Lewy body disease (Lewy body dementia) Brain 110 1987 1131 1153
78. M Goedert R Jakes R.A Crowther M Hasegawa M.J Smith M.G Spillantini Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases Biochem. Soc. Trans. 2 1998 463 471
79. M.S Goldberg P.T Lansbury Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2 2000 E115 119
80. J.M Gorell C.C Johnson B.A Rybicki E.L Peterson G.X Kortsha G.G Brown R.J Richardson Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease Neurology 50 1998 1346 1350
81. J.P Graham D.R Oppenheimer Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy J. Neurol. Neurosurg. Psychiat. 32 1969 28 34
82. W Halliday The nosology of Hallervorden-Spatz disease J. Neurol. Sci. 134 1995 84 91
83. H Han P.H Weinreb P.T Lansbury The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2 1995 163 169
84. L Hansen D.P Salmon D Galasko E Masliah R Katzman R DeTeresa L.J Thal M.M Pay R Hofstetter M Klauber V Rice N Butters M Alford The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity Neurology 40 1990 1 8
85. V Haroutunian M Serby D.P Purohit D.P Perl D Marin M Lantz R.C Mohs K.L Davis Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions Arch. Neurol. 57 2000 1145 1150
86. M Hashimoto L.J Hsu A Sisk Y Xia A Takeda M Sundsmo E Masliah Human recombinant NACP⧸alpha-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease Brain Res. 799 1998 301 306
87. M Hashimoto E Rockenstein M Mante M Mallory E Masliah Beta-synuclein inhibits alpha-synuclein aggregation: A possible role as an anti-Parkinsonian factor Neuron 32 2001 213 223
88. M Hashimoto M Yoshimoto A Sisk L.J Hsu M Sundsmo A Kittel T Saitoh A Miller E Masliah NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation Biochem. Biophys. Res. Commun. 237 1997 611 616
89. C Hertzman M Wiens D Bowering B Snow D Calne Parkinson's disease: A case-control study of occupational and environmental risk factors Am. J. Ind. Med. 17 1990 349 355
90. W.D Hill V.M.-Y Lee H.I Hurtig J.M Murray J.Q Trojanowski Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies J. Comp. Neurol. 309 1991 150 160
91. M.M Hoehn M.D Yahr Parkinsonism: Onset, progression and mortality Neurology 17 1967 427 442
92. A.J Hughes S.E Daniel S Blankson A.J Lees A clinicopathological study of 100 cases of Parkinson's disease Arch. Neurol. 50 1993 140 148
93. R.E Huie S Padmaja The reaction of NO with superoxide Free Radic. Res. Commun. 18 1993 195 199
94. H.I Hurtig J.Q Trojanowski J.E Galvin D Ewbank M.L Schmidt V.M.-Y Lee C Clark G Glosser M.B Stern S.M Gollomp S.E Arnold Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease Neurology 54 2000 1916 1921
95. M Ingelsson B.T Hyman Disordered proteins in dementia Ann. Med. 34 2002 259 271
96. S Inoue S Kawanishi Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide FEBS Lett. 371 1995 86 88
97. M.C Irizarry W Growdon T Gomez-Isla K Newell J.M George D.F Clayton B.T Hyman Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity J. Neuropathol. Exp. Neurol. 57 1998 334 337
98. H Ischiropoulos Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species Arch. Biochem. Biophys. 356 1998 1 11
99. H Ischiropoulos A.B al Mehdi Peroxynitrite-mediated oxidative protein modifications FEBS Lett. 364 1995 279 282
100. H Ischiropoulos J.S Beckman Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J. Clin. Invest. 111 2003 163 169
101. A Iwai E Masliah M Yoshimoto N Ge L Flanagan H.A de Silva A Kittel T Saitoh The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system Neuron 14 1995 467 475
102. A Iwai M Yoshimoto E Masliah T Saitoh Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic Biochemistry 34 1995 10139 10145
103. K Iwanaga K Wakabayashi M Yoshimoto I Tomita H Satoh H Takashima A Satoh M Seto M Tsuijihata H Takahashi Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases Neurology 52 1999 1269 1271
104. R Jakes M.G Spillantini M Goedert Identification of two distinct synucleins from human brain FEBS Lett. 345 1994 27 32
105. J Jankovic J.B Kirkpatrick K.A Bloomquist P.J Langlias E.D Bird Late onset Hallervorden-Spatz disease presenting as familial parkinsonism Neurology 35 1985 227 234
106. K Jellinger Neuroaxonal dystrophy: Its natural history and related disorders “Progress in Neuropathology,” 1973 Grune and Stratton New York 129 180
107. J.M Jenco A Rawlingson B Daniels A.J Morris Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins Biochemistry 37 1998 4901 4909
108. P.H Jensen H Hager M.S Nielsen P Hojrup J Gliemann R Jakes alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356 J. Biol. Chem. 274 1999 25481 25489
109. P.H Jensen M.S Nielsen R Jakes C.G Dotti M Goedert Binding of alpha-Synuclein to brain vesicles is abolished by familial Parkinson's disease mutation J. Biol. Chem. 273 1998 26292 26294
110. H Ji Y Liu T Jia M Wang J Liu G Xiao B.K Joseph C Rosen Y.E Shi Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing Cancer Res. 57 1997 759 764
111. F.J Jimenez-Jimenez D Mateo S Gimenez-Roldman Exposure to well water and pesticides in Parkinson's disease: A case-control study in the Madrid area Mov. Disord. 7 1992 149 152
112. E Jo N Fuller R.P Rand P George-Hyslop P.E Fraser Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein J. Mol. Biol. 315 2002 799 807
113. E Jo J McLaurin C.M Yip P George-Hyslop P.E Fraser alpha-Synuclein membrane interactions and lipid specificity J. Biol. Chem. 275 2000 34328 34334
114. E Junn M.M Mouradian Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine Neurosci. Lett. 320 2002 146 150
115. P.J Kahle M Neumann L Ozmen V Muller H Jacobsen A Schindzielorz M Okochi U Leimer P.H van Der A Probst E Kremmer H.A Kretzschmar C Haass Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain J. Neurosci. 20 2000 6365 6373
116. R Katzman D Galasko T Saitoh L.J Thal L Hansen Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease Brain Cogn. 28 1995 259 265
117. H Kaufmann K Hague D Perl Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure Neurology 56 2001 980 981
118. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu Mutations in the parkin gene cause autosomal-recessive juvenile parkinsonism Nature 392 1998 605 608
119. L.W Ko N.D Mehta M Farrer C Easson J Hussey S Yen J Hardy S.H Yen Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein J. Neurochem. 75 2000 2546 2554
120. K Kosaka Lewy bocies in cerebral cortex: Report of three cases Acta Neuropathol. 42 1978 127 134
121. K Kosaka Diffuse Lewy body disease in Japan J. Neurol. 237 1990 197 204
122. K Kosaka E Iseki Dementia with Lewy bodies Curr. Opin. Neurol. 9 1996 271 275
123. S Krishnan E.Y Chi S.J Wood B.S Kendrick C Li W Garzon-Rodriguez J Wypych T.W Randolph L.O Narhi A.L Biere M Citron J.F Carpenter Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis Biochemistry 42 2003 829 837
124. R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek J.T Epplen L Schols O Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 1 1998 106 108
125. S Kuzuhara H Mori N Izumiyama M Yoshimura Y Ihara Lewy bodies are ubiquitinated: A light and electron microscopuc immunocytochemical study Acta Neuropathol. (Berl.) 75 1988 345 353
126. A.E Lang A.M Lozano Parkinson's disease: First of two parts N. Engl. J. Med. 339 1998 1044 1053
127. J.W Langston P Ballard J.W Tetrud I Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
128. J.W Langston L.S Forno J Tetrud A.G Reeves J.A Kaplan D Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605
129. P.L Lantos Multiple system atrophy Brain Pathol. 7 1997 1293 1297
130. H.A Lashuel B.M Petre J Wall M Simon R.J Nowak T Walz P.T Lansbury Jr. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils J. Mol. Biol. 322 2002 1089 1102
131. C Lavedan The synuclein family Genome Res. 8 1998 871 880
132. C Lavedan E Leroy A Dehejia S Buchholtz A Dutra R.L Nussbaum M.H Polymeropoulos Identification, localization and characterization of the human gamma-synuclein gene Hum. Genet. 103 1998 106 112
133. F.J Lee F Liu Z.B Pristupa H.B Niznik Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB J. 15 2001 916 926
134. M.K Lee W Stirling Y Xu X Xu D Qui A.S Mandir T.M Dawson N.G Copeland N.A Jenkins D.L Price Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53-Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice Proc. Natl. Acad. Sci. USA 99 2002 8968 8973
135. V.M.-Y Lee M Goedert J.Q Trojanowski Neurodegenerative tauopathies Annu. Rev. Neurosci. 24 2001 1121 1159
136. F Lewy “Handbuch der Neurologie.” 1912 Springer Verlag Berlin
137. J Li V.N Uversky A.L Fink Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein Biochemistry 40 2001 11604 11613
138. H.-H Liou R.-C Chen Y.-F Tsai W.-P Chen Y.-C Chang M.-C Tsai Effects of paraquat on the substantia nigra of the Wistar rats: Neurochemical, histological, and behavioral studies Toxicol. Appl. Pharmacol. 137 1996 34 41
139. H.-H Liou M.-C Tsai C.J Chen J.S Jeng Y.-C Chang S.Y Chen R.-C Chen Environmental risk factors and Parkinson's disease: A case-control study in Taiwan Neurology 48 1997 1583 1588
140. C.F Lippa H Fujiwara D.M Mann B Giasson M Baba M.L Schmidt L.E Nee B O'Connell D.A Pollen P George-Hyslop B Ghetti D Nochlin T.D Bird N.J Cairns V.M.-Y Lee T Iwatsubo J.Q Trojanowski Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes Am. J. Pathol. 153 1998 1365 1370
141. C.F Lippa M.L Schmidt V.M.-Y Lee J.Q Trojanowski Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease Ann. Neurol. 45 1999 353 357
142. J Lotharius P Brundin Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein Nat. Rev. Neurosci. 3 2002 1 11
143. E.D Louis S Fahn Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease: Do the parkinsonian features differ? Adv. Neurol. 69 1996 311 314
144. E.D Louis L.A Klatka Y Liu S Fahn Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease Neurology 48 1997 376 380
145. V.M Mann J.M Cooper D Krige S.E Daniel A.H Schapira C.D Marsden Brain, skeletal, muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 1992 33 42
146. A.B Manning-Bog A.L McCormack J Li V.N Uversky A.L Fink D.A Di Monte The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: Paraquat and alpha-synuclein J. Biol. Chem. 277 2002 1641 1644
147. A.B Manning-Bog A.L McCormack M.G Purisai L.M Bolin D.A Di Monte alpha-Synuclein overexpression protects against paraquat-induced neurodegeneration J. Neurosci. 23 2003 3095 3099
148. L Maroteaux J.T Campanelli R.H Scheller Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal J. Neurosci. 8 1988 2804 2815
149. L Maroteaux R.H Scheller The rat brain synucleins: Family of proteins transiently associated with neuronal membrane Brain Res. Mol. Brain Res. 11 1991 335 343
150. R.J Marttila U.K Rinne Dementia in Parkinson disease Acta Neurol. Scand. 54 1976 431 441
151. E Masliah E Rockenstein I Veinbergs M Mallory M Hashimoto A Takeda Y Sagara A Sisk L Mucke Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders Science 287 2000 1265 1269
152. A Matsuo I Akigushi G.C Lee E.G McGeer P.L MrGeer J Kimura Myelin degeneration in multiple system atrophy detected by unique antibodies Am. J. Pathol. 153 1998 735 744
153. Y Matsuoka M Vila S Lincoln A McCormack M Picciano J LaFrancois X Yu D Dickson W.J Langston E McGowan M Farrer J Hardy K Duff S Przedborski D.A Di Monte Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter Neurobiol. Dis. 8 2001 535 539
154. R Mayeau J Chen E Mirabello K Marder K Bell G Dooneief L Cote Y Stern An estimate of the incidence of dementia in idiopathic Parkinson's disease Neurology 40 1990 1513 1517
155. R Mayeau Y Stern L Cote J.B Williams Altered serotonin metabolism in depressed patients with Parkinson's disease Neurology 34 1984 642 646
156. A.L McCormack M Thiruchelvam A.B Manning-Bog C Thiffault J.W Langston D.A Cory-Slechta D.A Di Monte Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons casued by the nerbicide paraquat Neurobiol. Dis. 10 2002 119 127
157. I.G McKeith D Galasko K Kosaka E.K Perry D.W Dickson L.A Hansen D.P Salmon J Lowe S.S Mirra E.J Byrne G Lennox N.P Quinn J.A Edwardson P.G Ince C Bergeron A Burns B.L Miller S Lovestone D Collerton E.N Jansen C Ballard R.A De Vos G.K Wilcock K.A Jellinger R.H Perry Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
158. P.J McLean H Kawamata S Ribich B.T Hyman Membrane association and protein conformation of alpha-synuclein in intact neurons J. Biol. Chem. 275 2000 8812 8816
159. M.S Mega D.L Masterman D.F Benson H.V Vinters U Tomiyasu A.H Craig D.J Foti D Kaufer D.W Scharre L Fairbanks J.L Cummings Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria Neurology 47 1996 1403 1409
160. E Mezey A Dehejia G Harta N Tresser S.F Suchy R.L Nussbaum M.J Brownstein M.H Polymeropoulos Alpha-synuclein is present in Lewy bodies in sporadic Parkinson's disease Mol. Psychiat. 3 1998 493 499
161. F Mori C Inenaga M Yoshimoto H Umezu R Tanaka H Takahashi K Wakabayashi Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells Acta Neuropathol. (Berl.) 103 2002 145 151
162. D.D Murphy S.M Rueter J.Q Trojanowski V.M.-Y Lee Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J. Neurosci. 20 2000 3214 3220
163. I.V Murray B Giasson S.M Quinn V Koppaka P.H Axelsen H Ischiropoulos J.Q Trojanowski V.M.-Y Lee Role of alpha-synuclein carboxy-terminus on fibril formation in vitro Biochemistry 42 2003 8530 8540
164. S Nakajo S Shioda Y Nakai K Nakaya Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization Brain Res. Mol. Brain Res. 27 1994 81 86
165. S Nakajo K Tsukada H Kameyama Y Furuyama K Nakaya Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: Its levels as determined by enzyme immunoassay Brain Res. 741 1996 180 184
166. V Narayanan S Scarlata Membrane binding and self-association of alpha-synucleins Biochemistry 40 2001 9927 9934
167. L Narhi S.J Wood S Steavenson Y Jiang G.M Wu D Anafi S.A Kaufman F Martin K Sitney P Denis J.C Louis J Wypych A.L Biere M Citron Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation J. Biol. Chem. 274 1999 9843 9846
168. W.J Nicklas R.E Heikkila Inhibition of NADH-linked oxidation in brain metochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine Life Sci. 36 1985 2503 2508
169. N.N Ninkina M.V Alimovakost J.W.E Peterson L Delaney B.B Cohen S Imreh N.V Gnuchev A.M Davies V.L Buchman Organization, expression and polymorphism of the human persyn gene Hum. Mol. Genet. 7 1998 1417 1424
170. N.N Ninkina E.M Privalova L.G Pinon A.M Davies V.L Buchman Developmentally regulated expression of persyn, a member of the synuclein family, in skin Exp. Cell Res. 246 1999 308 311
171. K Nishiyama S Murayama Y Nishimura K Asayama I Kanazawa Superoxide dismutase-like immunoreactivity in spheroids in Hallervorden-Spatz disease Acta Neuropathol. 93 1997 19 23
172. E.H Norris B.I Giasson H Ischiropoulos V.M.-Y Lee Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications J. Biol. Chem. 278 2003 27239 27240
173. H Okazaki L Lipkin S Aronson Diffuse intracytoplasmic inclusions (Lewy type) associated with progressive dementia and quadriparesis J. Neuropathol. Exp. Neurol. 20 1961 237 244
174. E.J Olson B.F Boeve M.H Silber Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases Brain 123 2000 331 339
175. N Ostrerova L Petrucelli M Farrer N Mehta P Choi J Hardy B Wolozin alpha-Synuclein shares physical and functional homology with 14-3-3 proteins J. Neurosci. 19 1999 5782 5791
176. N Ostrerova-Golts L Petrucelli J Hardy J.M Lee M Farrer B Wolozin The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity J. Neurosci. 20 2000 6048 6054
177. S.R Paik H.J Shin J.H Lee Metal-catalyzed oxidation of alpha-synuclein in the presence of copper(II) and hydrogen peroxide Arch. Biochem. Biophys. 378 2000 269 277
178. S.R Paik H.J Shin J.H Lee C.S Chang J Kim Copper(II)-induced self-oligomerization of alpha-synuclein Biochem. J. 340 1999 821 828
179. B Pakkenberg A Moller H.J Gundersen D.A Mouritzen H Pakkenberg The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method J. Neurol. Neurosurg. Psychiat. 54 1991 30 33
180. M Papp J Kahn P Lantos Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrom) J. Neurol. Sci. 94 1989 79 100
181. J.Y Park P.T Lansbury Jr. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: A possible therapeutic strategy against Parkinson's disease Biochemistry 42 2003 3696 3700
182. J Parkinson “An Essay on the Shaking Palsy.” 1817 Sherwood, Neely & Jones London
183. E Paxinou Q Chen M Weisse B.I Giasson E.H Norris S.M Rueter J.Q Trojanowski V.M.-Y Lee H Ischiropoulos Induction of alpha-synuclein aggregation by intracellular nitrative insult J. Neurosci. 21 2001 8053 8061
184. J.E Payton R.J Perrin D.F Clayton J.M George Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells Brain Res. Mol. Brain Res. 95 2001 138 145
185. R.J Perrin W.S Woods D.F Clayton J.M George Interaction of human alpha-synuclein and Parkinson's disease variants with phospholipids: Structural analysis using site-directed mutagenesis J. Biol. Chem. 275 2000 34393 34398
186. R.H Perry D Irving G Blessed A Fairbairn E.K Perry Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly J. Neurol. Sci. 95 1990 119 139
187. R.H Perry D Irving G Blessed A Fairbairn E.K Perry Senile dementia of Lewy body dementia J. Neurol. Sci. 95 2000 119 139
188. M.S Pollanen D.W Dickson C Bergeron Pathology and biology of the Lewy body J. Neuropathol. Exp. Neurol. 52 1993 183 191
189. M.H Polymeropoulos C Lavedan E Leroy S.E Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer E.S Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos W.G Johnson A.M Lazzarini R.C Duvoisin G Di Iorio L.I Golbe R.L Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
190. A.N Pronin A.J Morris A Surguchov J.L Benovic Synucleins are a novel class of substrates for G protein-coupled receptor kinases J. Biol. Chem. 275 2000 26515 26522
191. M.C Quilty W.P Gai D.L Pountney A.K West J.C Vickers Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma Exp. Neurol. 182 2003 195 207
192. R Radi J.S Beckman K.M Bush B.A Freeman Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide Arch. Biochem. Biophys. 288 1991 481 487
193. R Radi J.S Beckman K.M Bush B.A Freeman Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide J. Biol. Chem. 266 1991 4244 4250
194. A.H Rajput K.P Offord C.M Beard L.T Kurland A case control study of smoking habits, dementia, and other illness in idiopathic Parkinson's disease Neurology 37 1987 226 232
195. P Rezaie N.J Cairns A Chadwick P.L Lantos Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease Neurosci. Lett. 212 1996 111 114
196. C Richter-Landsberg M Gorath J.Q Trojanowski V.M.-Y Lee Alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes J. Neurosci. Res. 62 2000 9 14
197. J.E Riggs A controlled study of dementia in Parkinson's disease J. Neurol. Neurosurg. Psychiat. 45 1993 969 974
198. Y Saito M Kawai K Inoue R Sasaki H Arai E Nanba S Kuzuhara Y Ihara I Kanazawa S Murayama Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course J. Neurol. Sci. 177 2000 48 59
199. M.G Salgo K Stone G.L Squadrito J.R Battista W.A Pryor Peroxynitrite cases DNA nicks in plasmid pBR322 Biochem. Biophys. Res. Commun. 210 1995 1025 1030
200. W Samuel D Galasko E Masliah L.A Hansen Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease J. Neurosci. 55 1996 44 52
201. M.L Schmidt J Murray V.M.-Y Lee W.D Hill A Wertkin J.Q Trojanowski Epitope map of neurofilament protein domains in cortical and peropheral nervous system Lewy bodies Am. J. Pathol. 139 1991 53 65
202. J Segrest H De Loof J Dohlman C Brouilette G Anantharamaiah Amphopathic helix motif: Classes and properties Proteins 8 1990 103 117
203. J Segrest M Jones H De Loof C Brouilette Y Venkatacchalapathi G Anantharamaiah The amphipathic helix in exchangeable apolipoproteins: A review of secondary structure and function J. Lipid Res. 33 1992 141 166
204. K.M Semchuk E.J Love R.G Lee Parkinson's disease: A test of the multifactorial etiologic hypothesis Neurology 43 1993 1173 1180
205. L.C Serpell J Berriman R Jakes M Goedert R.A Crowther Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation Proc. Natl. Acad. Sci. USA 97 2000 4897 4902
206. T.B Sherer R Betarbet A.K Stout S Lund M Baptista A.V Panov M.R Cookson J.T Greenamyre An in vitro model of Parkinson's disease: Linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J. Neurosci. 22 2002 7006 7015
207. T.B Sherer J.-H Kim R Betarbet J.T Greenamyre Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp. Neurol. 179 2003 9 16
208. T Shibayama-Imazu K Ogane Y Hasegawa S Nakajo S Shioda H Ochiai Y Nakai K Nakaya Distribution of PNP 14 (beta-synuclein) in neuroendocrine tissues: Localization in Sertoli cells Mol. Reprod. Dev. 50 1998 163 169
209. T Shibayama-Imazu I Okahashi K Omata S Nakajo H Ochiai Y Nakai T Hama Y Nakamura K Nakaya Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14) Brain Res. 622 1993 17 25
210. E.C Shin S.E Cho D.K Lee M.W Hur S.R Paik J.H Park J Kim Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages Mol. Cells 10 2000 65 70
211. G.M Shy G.A Drager A neurologic syndrome associated with orthostatic hypotension Arch. Neurol. 2 1960 511 527
212. J.M Souza B.I Giasson Q Chen V.M.-Y Lee H Ischiropoulos Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers: Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J. Biol. Chem. 275 2000 18344 18349
213. J.M Souza B.I Giasson V.M.-Y Lee H Ischiropoulos Chaperone-like activity of synucleins FEBS Lett. 474 2000 116 119
214. M.G Spillantini R.A Crowther R Jakes N.J Cairns P.L Lantos M Goedert Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Neurosci. Lett. 251 1998 205 208
215. M.G Spillantini R.A Crowther R Jakes M Hasegawa M Goedert alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. USA 95 1998 6469 6473
216. M.G Spillantini A Divane M Goedert Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35 Genomics. 27 1995 379 381
217. M.G Spillantini M.L Schmidt V.M.-Y Lee J.Q Trojanowski R Jakes M Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
218. H Sugiyama J.A Hainfellner B Schid-Siegal H Budka Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult Clin. Neuropathol. 12 1993 147 153
219. A Surguchov R.E Palazzo I Surgucheva Gamma synuclein: Subcellular localization in neuronal and non-neuronal cells and effect on signal transduction Cell. Motil. Cytoskel. 49 2001 218 228
220. K.F Swaiman Hallervorden-Spatz syndrome and brain iron metabolism Arch. Neurol. 48 1991 1285 1293
221. R.H Swerdlow J.K Parks S.W Miller J.B Tuttle P.A Trimmer J.P Sheehan J.P Bennett R.E Davis W.D Parker Origin and functional consequences of the complex I defect in Parkinson's disease Ann. Neurol. 40 1996 663 671
222. S.J Tabrizi M Orth J.M Wilkinson J.W Taanman T.T Warner J.M Cooper A.H Schapira Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity Hum. Mol. Genet. 9 2000 2683 2689
223. A Takeda M Mallory M Sundsmo W.G Honer L Hansen E Masliah Abnormal accumulation of NACP⧸alpha-synuclein in neurodegenerative disorders Am. J. Pathol. 152 1998 367 372
224. E Tandberg J.P Larsen D Aarsland J.L Cummings The occurence of depression in Parkinson's disease: A community-based study Arch. Neurol. 53 1996 175 179
225. K Tanji F Mori S Nakajo T Imaizumi H Yoshida T Hirabayashi M Yoshimoto K Satoh H Takahashi K Wakabayashi Expression of beta-synuclein in normal human astrocytes Neuroreport 12 2001 2845 2848
226. C.M Tanner B Chen W Wang M Peng Z Liu X Liang L.C Kao D.W Gilley C.G Goetz B.G Schoenberg Environmental factors and Parkinson's disease: A case-control study in China Neurology 39 1989 660 664
227. C.M Tanner S.M Goldman Epidemiology of Parkinson's disease Neurol. Clin. 14 1996 317 335
228. T.D Taylor M Litt P Kramer M Pandolfo L Angelini N Nardocci S Davis M Pineda H Hattori P.J Flett M.R Cilio E Bertini S.J Hayflick Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13 Nat. Genet. 14 1996 479 481
229. K.F Tipton T.P Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J. Neurochem. 61 1993 1191 1206
230. A.A Tiunova K.V Anokhin A.R Saha O Schmidt D.P Hanger B.H Anderton A.M Davies N.N Ninkina V.L Buchman Chicken synucleins: Cloning and expression in the developing embryo Mech. Dev. 99 2000 195 198
231. T Tobe S Nakajo A Tanaka A Mitoya K Omata K Nakaya M Tomita Y Nakamura Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein J. Neurochem. 59 1992 1624 1629
232. Y Trembath C Rosenberg J.F Ervin D.E Schmechel P Gaskell M Perica Vance J Vance C.M Hulette Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease Acta Neuropathol. (Berl.) 105 2003 484 488
233. R.C Tripathi B.J Tripathi S.C Bauserman J.K Park Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome Acta Neuropathol. 83 1992 113 119
234. P.H Tu J.E Galvin M Baba B Giasson T Tomita S Leight S Nakajo T Iwatsubo J.Q Trojanowski V.M.-Y Lee Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein Ann. Neurol. 44 1998 415 422
235. K Ueda H Fukushima E Masliah Y Xia A Iwai M Yoshimoto D.A Otero J Kondo Y Ihara T Saitoh Molecular cloning of cDNA encoding an unrecognizable component of amyloid in Alzheimer disease Proc. Natl. Acad. Sci. USA 90 1993 11282 11286
236. V.N Uversky A.L Fink Amino acid determinants of alpha-synuclein aggregation: Putting together pieces of the puzzle FEBS Lett. 522 2002 9 13
237. V.N Uversky J Li A.L Fink Evidence for a partially folded intermediate in alpha-synuclein fibril formation J. Biol. Chem. 276 2001 10737 10744
238. V.N Uversky J Li A.L Fink Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein: A possible molecular link between Parkinson's disease and heavy metal exposure J. Biol. Chem. 276 2001 44284 44296
239. V.N Uversky J Li A.L Fink Pesticides directly accelerate the rate of alpha-synuclein fibril formation: A possible factor in Parkinson's disease FEBS Lett. 500 2001 105 108
240. V.N Uversky G Yamin P.O Souillac J Goers C.B Glaser A.L Fink Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Lett. 517 2002 239 244
241. A van der Vliet C.A O'Neill B Halliwell C.E Cross H Kaur Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite: Evidence for hydroxyl radical production from peroxynitrite FEBS Lett. 339 1994 89 92
242. K Wakabayashi M Yoshimoto T Fukushima R Koide Y Horikawa T Morita H Takahashi Widespread occurrence of alpha-synuclein⧸NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies Neuropathol. Appl. Neurobiol. 25 1999 363 368
243. P.H Weinreb W Zhen A.W Poon K.A Conway P.T Lansbury Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded Biochemistry 35 1996 13709 13715
244. G.K Wenning Y Ben-Shlomo M Magalhaes S.E Daniel N.P Quinn Clinical features and natural history of multiple system atrophy: An analysis of 100 cases Brain 117 1994 835 845
245. G.K Wenning Y Ben-Shlomo M Magalhaes S.E Daniel N.P Quinn Clinicopathological study of 35 cases of multiple system atrophy J. Neurol. Neurosurg. Psychia. 58 1995 160 166
246. G.K Wenning F Tison Y Ben-Shlomo S.E Daniel N.P Quinn Multiple system atrophy: A review of 203 pathologically proven cases Mov. Disord. 12 1997 133 147
247. C Wersinger A Sidhu Attenuation of dopamine transporter activity by alpha-synuclein Neurosci. Lett. 340 2003 189 192
248. P.J Whitehouse J.C Hedreen C.L White D.L Price Basal forebrain neurons in the dementia of Parkinson's disease Ann. Neurol. 13 1983 243 248
249. G.S Withers J.M George G.A Banker D.F Clayton Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons Brain Res. Dev. Brain Res. 99 1997 87 94
250. S.J Wood J Wypych S Steavenson J.C Louis M Citron A.L Biere Alpha-synuclein fibrillogenesis is nucleation-dependent: Implications for the pathogenesis of Parkinson's disease J. Biol. Chem. 274 1999 19509 19512
251. M Yamazaki Y Arai M Baba T Iwatsubo O Mori Y Katayama K Oyanagi Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam J. Neuropathol. Exp. Neurol. 59 2000 585 591
252. G Yamin C.B Glaser V.N Uversky A.L Fink Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein J. Biol. Chem. 278 2003 27630 27635
253. G Yamin V.N Uversky A.L Fink Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers FEBS Lett. 542 2003 147 152
254. M Yoshimoto A Iwai D Kang D.A Otero Y Xia T Saitoh NACP, the precursor protein of the non-amyloid beta⧸A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation Proc. Natl. Acad. Sci. USA 92 1995 9141 9145
255. B Zhou S.K Westaway B Levinson M.A Johnson J Gitschier S.J Hayflick A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome Nat. Genet. 28 2001 345 349
256. M.L Zupanc R.W CHun E.F Gilbert-Barness Osmiophilic deposits in cytosomes in Hallervorden-Spatz syndrome Pediatr. Neurol. 6 1990 349 352